About Us

Heat Biologics, a NightHawk Biosciences company located in Morrisville, NC, is developing first-in-class immunomodulators that realize the potential of the immune system to fight disease. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in a Phase 2 trial, various non-oncology programs in preclinical development and a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials. As part of the NightHawk ecosystem, the Company leverages a full suite of research and development capabilities to accelerate preclinical IND-enabling programs and utilize efficient clinical trial design to identify a fast, safe path for advancing the speed of medical innovation.